Establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell-derived insulin-producing cells.
Potential trend of regenerative treatment for type I diabetes has been introduced for more than a decade. However, the technologies regarding insulin-producing cell (IPC) production and transplantation are still being developed. Here, we propose the potential IPC production protocol employing mouse...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0318204 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832540277400666112 |
|---|---|
| author | Hong Thuan Tran Watchareewan Rodprasert Irma Padeta Saranyou Oontawee Steven Dwi Purbantoro Anatcha Thongsit Parkpoom Siriarchavatana Sayamon Srisuwatanasagul Hiroshi Egusa Thanaphum Osathanon Chenphop Sawangmake |
| author_facet | Hong Thuan Tran Watchareewan Rodprasert Irma Padeta Saranyou Oontawee Steven Dwi Purbantoro Anatcha Thongsit Parkpoom Siriarchavatana Sayamon Srisuwatanasagul Hiroshi Egusa Thanaphum Osathanon Chenphop Sawangmake |
| author_sort | Hong Thuan Tran |
| collection | DOAJ |
| description | Potential trend of regenerative treatment for type I diabetes has been introduced for more than a decade. However, the technologies regarding insulin-producing cell (IPC) production and transplantation are still being developed. Here, we propose the potential IPC production protocol employing mouse gingival fibroblast-derived induced pluripotent stem cells (mGF-iPSCs) as a resource and the pre-clinical approved subcutaneous IPC transplantation platform for further clinical confirmation study. With a multi-step induction protocol, the functional and matured IPCs were generated by 13 days with a long-term survival capability. Further double encapsulation of mGF-iPSC-derived IPCs (mGF-iPSC-IPCs) could preserve the insulin secretion capacity and the transplantation potential of the generated IPCs. To address the potential on IPC transplantation, a 2-step subcutaneous transplantation procedure was established, comprising 1) vascularized subcutaneous pocket formation and 2) encapsulated IPC bead transplantation. The in vivo testing confirmed the safety and efficiency of the platform along with less inflammatory response which may help minimize tissue reaction and graft rejection. Further preliminary in vivo testing on subcutaneous IPC-bead transplantation in an induced type I diabetic mouse model showed beneficial trends on blood glucose control and survival rate sustainability of diabetic mice. Taken together, an established mGF-iPSC-IPC generation protocol in this study will be the potential backbone for developing the iPSC-derived IPC production employing human and animal cell resources. As well as the potential further development of IPC transplantation platform for diabetes treatment in human and veterinary practices using an established subcutaneous encapsulated IPC-bead transplantation platform presented in this study. |
| format | Article |
| id | doaj-art-bd5cb538ab9643c098e6c90d9bba33e0 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-bd5cb538ab9643c098e6c90d9bba33e02025-02-05T05:31:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201e031820410.1371/journal.pone.0318204Establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell-derived insulin-producing cells.Hong Thuan TranWatchareewan RodprasertIrma PadetaSaranyou OontaweeSteven Dwi PurbantoroAnatcha ThongsitParkpoom SiriarchavatanaSayamon SrisuwatanasagulHiroshi EgusaThanaphum OsathanonChenphop SawangmakePotential trend of regenerative treatment for type I diabetes has been introduced for more than a decade. However, the technologies regarding insulin-producing cell (IPC) production and transplantation are still being developed. Here, we propose the potential IPC production protocol employing mouse gingival fibroblast-derived induced pluripotent stem cells (mGF-iPSCs) as a resource and the pre-clinical approved subcutaneous IPC transplantation platform for further clinical confirmation study. With a multi-step induction protocol, the functional and matured IPCs were generated by 13 days with a long-term survival capability. Further double encapsulation of mGF-iPSC-derived IPCs (mGF-iPSC-IPCs) could preserve the insulin secretion capacity and the transplantation potential of the generated IPCs. To address the potential on IPC transplantation, a 2-step subcutaneous transplantation procedure was established, comprising 1) vascularized subcutaneous pocket formation and 2) encapsulated IPC bead transplantation. The in vivo testing confirmed the safety and efficiency of the platform along with less inflammatory response which may help minimize tissue reaction and graft rejection. Further preliminary in vivo testing on subcutaneous IPC-bead transplantation in an induced type I diabetic mouse model showed beneficial trends on blood glucose control and survival rate sustainability of diabetic mice. Taken together, an established mGF-iPSC-IPC generation protocol in this study will be the potential backbone for developing the iPSC-derived IPC production employing human and animal cell resources. As well as the potential further development of IPC transplantation platform for diabetes treatment in human and veterinary practices using an established subcutaneous encapsulated IPC-bead transplantation platform presented in this study.https://doi.org/10.1371/journal.pone.0318204 |
| spellingShingle | Hong Thuan Tran Watchareewan Rodprasert Irma Padeta Saranyou Oontawee Steven Dwi Purbantoro Anatcha Thongsit Parkpoom Siriarchavatana Sayamon Srisuwatanasagul Hiroshi Egusa Thanaphum Osathanon Chenphop Sawangmake Establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell-derived insulin-producing cells. PLoS ONE |
| title | Establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell-derived insulin-producing cells. |
| title_full | Establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell-derived insulin-producing cells. |
| title_fullStr | Establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell-derived insulin-producing cells. |
| title_full_unstemmed | Establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell-derived insulin-producing cells. |
| title_short | Establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell-derived insulin-producing cells. |
| title_sort | establishment of subcutaneous transplantation platform for delivering induced pluripotent stem cell derived insulin producing cells |
| url | https://doi.org/10.1371/journal.pone.0318204 |
| work_keys_str_mv | AT hongthuantran establishmentofsubcutaneoustransplantationplatformfordeliveringinducedpluripotentstemcellderivedinsulinproducingcells AT watchareewanrodprasert establishmentofsubcutaneoustransplantationplatformfordeliveringinducedpluripotentstemcellderivedinsulinproducingcells AT irmapadeta establishmentofsubcutaneoustransplantationplatformfordeliveringinducedpluripotentstemcellderivedinsulinproducingcells AT saranyouoontawee establishmentofsubcutaneoustransplantationplatformfordeliveringinducedpluripotentstemcellderivedinsulinproducingcells AT stevendwipurbantoro establishmentofsubcutaneoustransplantationplatformfordeliveringinducedpluripotentstemcellderivedinsulinproducingcells AT anatchathongsit establishmentofsubcutaneoustransplantationplatformfordeliveringinducedpluripotentstemcellderivedinsulinproducingcells AT parkpoomsiriarchavatana establishmentofsubcutaneoustransplantationplatformfordeliveringinducedpluripotentstemcellderivedinsulinproducingcells AT sayamonsrisuwatanasagul establishmentofsubcutaneoustransplantationplatformfordeliveringinducedpluripotentstemcellderivedinsulinproducingcells AT hiroshiegusa establishmentofsubcutaneoustransplantationplatformfordeliveringinducedpluripotentstemcellderivedinsulinproducingcells AT thanaphumosathanon establishmentofsubcutaneoustransplantationplatformfordeliveringinducedpluripotentstemcellderivedinsulinproducingcells AT chenphopsawangmake establishmentofsubcutaneoustransplantationplatformfordeliveringinducedpluripotentstemcellderivedinsulinproducingcells |